Scholarly Index
Nadine Tung
Beth Israel Deaconess Medical Center; 29,933 total citations; 344 total publications; best world rank #13
Beth Israel Deaconess Medical Center
29,933Total citations
344Total publications
84H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| BRCA gene mutations in cancer | Lifetime | 43 | US 24 | 99.40 |
| PARP inhibition in cancer therapy | Lifetime | 58 | US 31 | 98.98 |
| Cancer Genomics and Diagnostics | Lifetime | 349 | US 206 | 99.34 |
| Advanced Breast Cancer Therapies | Lifetime | 149 | US 74 | 98.69 |
| DNA Repair Mechanisms | Lifetime | 449 | US 258 | 97.98 |
| Breast Cancer Treatment Studies | Lifetime | 877 | US 388 | 97.57 |
| Nutrition, Genetics, and Disease | Lifetime | 593 | US 257 | 93.84 |
| Male Breast Health Studies | Lifetime | 135 | US 55 | 86.06 |
| BRCA gene mutations in cancer | 2021-2025 | 13 | US 9 | 99.08 |
| PARP inhibition in cancer therapy | 2021-2025 | 54 | US 24 | 98.29 |
| Cancer Genomics and Diagnostics | 2021-2025 | 425 | US 198 | 97.16 |
| Breast Cancer Treatment Studies | 2021-2025 | 386 | US 128 | 95.79 |
| HER2/EGFR in Cancer Research | 2021-2025 | 300 | US 107 | 95.22 |
| Advanced Breast Cancer Therapies | 2021-2025 | 364 | US 133 | 93.40 |
| DNA Repair Mechanisms | 2021-2025 | 415 | US 178 | 86.97 |
| Cancer Risks and Factors | 2021-2025 | 904 | US 328 | 74.74 |